KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Net Margin: 2009-2024

Historic Net Margin for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to -11.89%.

  • Teva Pharmaceutical Industries' Net Margin rose 2599.00% to 9.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.77%, marking a year-over-year increase of 2735.00%. This contributed to the annual value of -11.89% for FY2024, which is 408.00% down from last year.
  • As of FY2024, Teva Pharmaceutical Industries' Net Margin stood at -11.89%, which was down 52.30% from -7.81% recorded in FY2023.
  • Teva Pharmaceutical Industries' Net Margin's 5-year high stood at -3.27% during FY2021, with a 5-year trough of -23.95% in FY2020.
  • Moreover, its 3-year median value for Net Margin was -11.89% (2024), whereas its average is -13.97%.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Net Margin skyrocketed by 2,068bps in 2021, and later slumped by 1,894bps in 2022.
  • Over the past 5 years, Teva Pharmaceutical Industries' Net Margin (Yearly) stood at -23.95% in 2020, then surged by 2,068bps to -3.27% in 2021, then plummeted by 1,894bps to -22.20% in 2022, then soared by 1,440bps to -7.81% in 2023, then tumbled by 408bps to -11.89% in 2024.